Vik Chopra

Q: What is Vik Chopra's success rate?

Vik Chopra currently has a success rate of 91.79240969364426.

Q: What is the average return of Vik Chopra's calls?

Their stock ratings have generated an average return of 26.506554069319815.

BMO Capital | Healthcare

Vik Chopra is an analyst from BMO Capital specializing in the Healthcare sector. Ranked #1214 out of 4716 analysts, they have issued 26 stock ratings with a success rate of 91.79% and an average return of 26.51%.

Vik Chopra has a well-established track record, with 26 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 91.79% and an average return of 26.51%, underscoring their expertise and ability to identify winning opportunities for investors.

#1214

Out of 4716

Total Ratings

+91.79%

Success Rate

+26.51%

Average Return

Recent Ratings Analysis

ZBH

Hold

Jul 09, 2026

Target

$95.00

Current

$87.56

Performance

—

Vik Chopra rated ZBH as Market Perform on Jul 09, 2026, setting a price target of 95. The Hold stance appears justified, as shares hovered around 87.56 with a % move.

ALGN

Buy

Jul 09, 2026

Target

$209.00

Current

$174.68

Performance

—

On Jul 09, 2026, ALGN was given a Outperform rating by Vik Chopra, with a target price of 209. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

ATEC

Buy

Jul 09, 2026

Target

$11.00

Current

$9.21

Performance

—

ATEC received a Outperform rating from Vik Chopra on Jul 09, 2026, aiming for 11. Price action was muted, as shares hovered around 9.21 despite the bullish outlook.

ENOV

Buy

Jul 09, 2026

Target

$29.00

Current

$23.63

Performance

—

On Jul 09, 2026, Vik Chopra published a Outperform outlook on ENOV, with a target of 29. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 23.63.

IART

Hold

Jul 09, 2026

Target

$19.00

Current

$17.30

Performance

—

Vik Chopra on Jul 09, 2026 assigned IART a Market Perform rating, with a price target of 19. The Hold stance reflected consolidation, as shares held near 17.3.

ISRG

Buy

Jul 09, 2026

Target

$518.00

Current

$415.10

Performance

—

On Jul 09, 2026, Vik Chopra reaffirmed ISRG with a Outperform rating, targeting 518. Market indecision has kept the 518 target in a holding pattern.

NVST

Hold

Jul 09, 2026

Target

$27.00

Current

$25.74

Performance

—

NVST was rated Market Perform by Vik Chopra on Jul 09, 2026, with a price objective of 27. Flat performance suggests the Hold view was reasonable.

TFX

Buy

Jul 09, 2026

Target

$159.00

Current

$130.35

Performance

—

On Jul 09, 2026, Vik Chopra initiated coverage on TFX with a Outperform rating and target of 159. Neutral price movement of % leaves room for interpretation.

SOLV

Hold

Feb 27, 2026

Target

$86.00

Current

$75.18

Performance

1.32%

Vik Chopra issued a Equal-Weight recommendation for SOLV on Feb 27, 2026, price target set at 86. The rating was appropriate for a consolidating market trading near 75.18.

XRAY

Hold

Feb 27, 2026

Target

$13.00

Current

$11.78

Performance

-19.75%

On Feb 27, 2026, XRAY was evaluated by Vik Chopra, who gave a Equal-Weight rating and target of 13. The Hold call avoided chasing into subsequent weakness of 19.75%.

GMED

Buy

Feb 26, 2026

Target

$104.00

Current

$76.20

Performance

-21.21%

Vik Chopra rated GMED as Overweight on Feb 26, 2026, setting a price target of 104. The stock has underperformed, dropping 21.21% despite the bullish target of 104.

HSIC

Hold

Feb 25, 2026

Target

$87.00

Current

$83.22

Performance

1.60%

On Feb 25, 2026, HSIC was given a Equal-Weight rating by Vik Chopra, with a target price of 87. Market indecision, reflected in sideways trading near 83.22, supported the cautious call.

MASI

Hold

Feb 18, 2026

Target

$190.00

Current

$179.95

Performance

2.47%

MASI received a Equal-Weight rating from Vik Chopra on Feb 18, 2026, aiming for 190. Shares remained flat at 179.95, aligning with the neutral rating.

CNMD

Hold

Jan 29, 2026

Target

$42.00

Current

$33.59

Performance

-9.97%

On Jan 29, 2026, Vik Chopra published a Equal-Weight outlook on CNMD, with a target of 42. Weakness in the stock, now at 33.59, supported the conservative rating.

NPCE

Buy

Nov 05, 2025

Target

$16.00

Current

$16.78

Performance

29.28%

Vik Chopra on Nov 05, 2025 assigned NPCE a Overweight rating, with a price target of 16. The Buy call aligned well with market performance, producing a gain of 29.28%.

Frequency Asked Questions

Who is Vik Chopra?

Vik Chopra is an analyst from BMO Capital specializing in the Healthcare sector.

What is Vik Chopra's success rate?

Vik Chopra currently has a success rate of +91.79%.

How many ratings has Vik Chopra issued?

Vik Chopra has issued 26 stock ratings so far.

What is the average return of Vik Chopra's calls?

Their stock ratings have generated an average return of +26.51%.

What is Vik Chopra's ranking?

Vik Chopra is ranked #1214 out of 4716 analysts.

What types of ratings does Vik Chopra give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Vik Chopra?

You can follow Vik Chopra by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Vik Chopra?

Their latest rating was a Hold on ZBH issued on 2026-07-09.